Cargando…

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines

In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence-based guidelines, 1 was an expert co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hee Ryung, Bahk, Won-Myong, Seo, Jeong Seok, Woo, Young Sup, Park, Young-Min, Jeong, Jong-Hyun, Kim, Won, Shim, Se-Hoon, Lee, Jung Goo, Jon, Duk-In, Min, Kyung Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565074/
https://www.ncbi.nlm.nih.gov/pubmed/28783928
http://dx.doi.org/10.9758/cpn.2017.15.3.199
_version_ 1783258358790225920
author Wang, Hee Ryung
Bahk, Won-Myong
Seo, Jeong Seok
Woo, Young Sup
Park, Young-Min
Jeong, Jong-Hyun
Kim, Won
Shim, Se-Hoon
Lee, Jung Goo
Jon, Duk-In
Min, Kyung Joon
author_facet Wang, Hee Ryung
Bahk, Won-Myong
Seo, Jeong Seok
Woo, Young Sup
Park, Young-Min
Jeong, Jong-Hyun
Kim, Won
Shim, Se-Hoon
Lee, Jung Goo
Jon, Duk-In
Min, Kyung Joon
author_sort Wang, Hee Ryung
collection PubMed
description In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence-based guidelines, 1 was an expert consensus-based guideline, and 1 was an amalgamation of both evidence and expert consensus-based recommendations. The recommendations in the KMAP-DD 2017 were generally similar to those in other global treatment guidelines, although there were some differences between the guidelines. The KMAP-DD 2017 appeared to reflect current changes in the psychopharmacology of depression quite well, like other recently published evidence-based guidelines. As an expert consensus-based guideline, the KMAP-DD 2017 had some limitations. However, considering there are situations in which clinical evidence cannot be drawn from planned clinical trials, the KMAP-DD 2017 may be helpful for Korean psychiatrists making decisions in the clinical settings by complementing previously published evidence-based guidelines.
format Online
Article
Text
id pubmed-5565074
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-55650742017-08-23 Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines Wang, Hee Ryung Bahk, Won-Myong Seo, Jeong Seok Woo, Young Sup Park, Young-Min Jeong, Jong-Hyun Kim, Won Shim, Se-Hoon Lee, Jung Goo Jon, Duk-In Min, Kyung Joon Clin Psychopharmacol Neurosci Review In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence-based guidelines, 1 was an expert consensus-based guideline, and 1 was an amalgamation of both evidence and expert consensus-based recommendations. The recommendations in the KMAP-DD 2017 were generally similar to those in other global treatment guidelines, although there were some differences between the guidelines. The KMAP-DD 2017 appeared to reflect current changes in the psychopharmacology of depression quite well, like other recently published evidence-based guidelines. As an expert consensus-based guideline, the KMAP-DD 2017 had some limitations. However, considering there are situations in which clinical evidence cannot be drawn from planned clinical trials, the KMAP-DD 2017 may be helpful for Korean psychiatrists making decisions in the clinical settings by complementing previously published evidence-based guidelines. Korean College of Neuropsychopharmacology 2017-08 2017-08-31 /pmc/articles/PMC5565074/ /pubmed/28783928 http://dx.doi.org/10.9758/cpn.2017.15.3.199 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Wang, Hee Ryung
Bahk, Won-Myong
Seo, Jeong Seok
Woo, Young Sup
Park, Young-Min
Jeong, Jong-Hyun
Kim, Won
Shim, Se-Hoon
Lee, Jung Goo
Jon, Duk-In
Min, Kyung Joon
Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
title Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
title_full Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
title_fullStr Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
title_full_unstemmed Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
title_short Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
title_sort korean medication algorithm for depressive disorder: comparisons with other treatment guidelines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565074/
https://www.ncbi.nlm.nih.gov/pubmed/28783928
http://dx.doi.org/10.9758/cpn.2017.15.3.199
work_keys_str_mv AT wangheeryung koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT bahkwonmyong koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT seojeongseok koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT wooyoungsup koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT parkyoungmin koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT jeongjonghyun koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT kimwon koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT shimsehoon koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT leejunggoo koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT jondukin koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines
AT minkyungjoon koreanmedicationalgorithmfordepressivedisordercomparisonswithothertreatmentguidelines